GeneMedicine vs Immupeutics Medicine

GeneMedicine logo

GeneMedicine

Biopharmaceutical company focusing on R&D and commercializing its oncolytic adenovirus platform for cancer treatment

11 employees · est. 2014 · Seoul, Korea South

VS
Immupeutics Medicine logo

Immupeutics Medicine

Advancing the future of tumor treatment through innovative research and application in immunotherapy

11-50 employees · est. 2018

GeneMedicine is the older company (2014 vs 2018).

Side-by-Side Comparison

GeneMedicine Immupeutics Medicine
Founded
2014 older 2018
Headquarters
Seoul, Korea South Not tracked yet
Employees
11 11-50
Industry
Not tracked yet Biotechnology
Funding Stage
Series A Seed
Total Funding
$15.00M $100.00M
Funding Rounds
1 3
Services
Gene Therapy Development, Research and Development, Contract Development and Manufacturing, Platform Technology Solutions, Biomedical Research Not tracked yet
Target Customers
Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Research Institutions, Patients with Chronic Illnesses Not tracked yet
Taxonomy
Oncolytic VirotherapyAdenovirus PlatformViral ImmunotherapyCancer TherapeuticsGene And Cell TherapyIntratumoral Administration +9 Biomedical ResearchImmunotherapyTumor TreatmentCancer TherapyOncology ResearchBiomedical Technology +4
Website
gene-medicine.com immupeutics.com
GeneMedicine logo

About GeneMedicine

GeneMedicine is a biopharmaceutical company established in 2014 and headquartered in Korea South, positioned at the forefront of viral immunotherapy for cancer treatment. Specializing in R&D and commercialization of an advanced oncolytic adenovirus platform, the startup is creating groundbreaking th...

Immupeutics Medicine logo

About Immupeutics Medicine

Immupeutics Medical Technology Co., Ltd. is a **biomedical research company** founded in **2018** with a focus on advancing the future of tumor treatment through innovative research and application in immunotherapy. The company's slogan, "Advancing the future of tumor treatment through innovative re...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches GeneMedicine and Immupeutics Medicine for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when GeneMedicine or Immupeutics Medicine moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

GeneMedicine was founded in 2014, based in Seoul, Korea South, with 11 employees. GeneMedicine is a biopharmaceutical company established in 2014 and headquartered in Korea South, positioned at the forefront of viral immunotherapy for cancer treatment. Specializing in R&D and comme. Immupeutics Medicine was founded in 2018, with 11-50 employees. Immupeutics Medical Technology Co., Ltd. is a **biomedical research company** founded in **2018** with a focus on advancing the future of tumor treatment through innovative research and application in.
GeneMedicine has raised $15.00M and Immupeutics Medicine $100.00M. Latest stage: GeneMedicine Series A, Immupeutics Medicine Seed.

Compare GeneMedicine with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at GeneMedicine on 2 Mar 2026, and Immupeutics Medicine on 26 Jul 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes